Associate professor Rita Patel holds up a prototype wearable device designed to diagnosis exercise-induced laryngeal ...
A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with ...
The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate ...
Researchers in Zurich say they have developed a method to use microrobots delivering stem cell therapies to treat spinal cord ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Current therapies for rheumatoid arthritis rely on sustained immunosuppression rather than restoration of immune tolerance, with off-drug remission remaining rare.
This milestone establishes hNPC01 as the world’s first forebrain neural progenitor cell therapy to receive FDA RMAT designation. It also marks the inaugural RMAT approval globally for any therapeutic ...
Muscle spasticity is a common and often debilitating consequence of spinal cord injury that can significantly affect mobility ...
Understanding the patterns of acquired resistance to epidermal growth factor receptor (EGFR) TKI treatment has led to more effective combination therapy and continues to drive development of novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results